ClinicalTrials.gg
RecruitingNCT07432841Updated Feb 25, 2026

Personalized High-Definition tDCS Protocols for Chronic Pain Treatment

An interventional study of Anodal High-Definition transcranial Direct Current Stimulation and Cathodal High-Definition transcranial Direct Current Stimulation in Chronic Pain, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 4 sites in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by Istituti Clinici Scientifici Maugeri SpA · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Apr 2025, registered Jan 2026).
  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 65 studies in Chronic Pain with a site in Italy — 19 open to participants now, 22 under way, none of them phase 3. Chronic Pain · Italy.

Planned enrollment
14th of 40
144 · median 73
Started
2025
with 9 others
No phase
27 of 65
8 open now
Primary completion
2027-02
later than 12 of 21 live
Registered
61st of 65
by date

Among the 65 studies in Chronic Pain with a site in Italy, this one is the 14th largest by planned enrollment of the 40 interventional ones that give a count, is one of 10 that started in 2025, is one of 27 with no phase, reaches primary completion later than 12 of the 21 other live ones, and was the 61st registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

19 of the 65 studies in Chronic Pain with a site in Italy are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Chronic Pain with a site in Italy, or all of them as a file.
02

Study summary

This study aims to examine the use of neurostimulation as a potential adjuvant treatment for chronic pain. Among neurostimulation techniques, transcranial direct current stimulation (tDCS) represents a promising, yet not fully exploited, option. Recent methodological advances allow for increased intensity and focality of its effects through personalized high-definition tDCS protocols (HD-tDCS), enabling targeted stimulation of specific brain regions involved in pain and analgesia processing, such as the dorsal anterior cingulate cortex (dACC).

Based on this evidence, the specific objective of the study is to investigate the effect of an innovative HD-tDCS protocol (personalized using structural and functional magnetic resonance imaging (fMRI)), with stimulation applied to the dACC. The experimental design involves randomly assigning 144 patients with chronic pain to three groups, who will undergo an intensive treatment (five sessions in the same week) with cathodal, anodal, or sham (placebo) HD-tDCS.

Patient recruitment and treatment will be equally distributed between sites located in Lombardy (IRCCS Maugeri-Pavia; University of Milano-Bicocca; n=72) and Palermo (IRCCS ISMETT-Palermo; University of Palermo; n=72).

The effects of neurostimulation will be: a) evaluated using self-reported measures of physical and social functioning (Brief Pain Inventory, BPI; primary outcome) before and after treatment, and at follow-up assessments at 3 weeks and 3 months; b) interpreted in relation to underlying neurophysiological changes, as revealed by the high spatial and temporal resolution provided, respectively, by fMR) and by transcranial magnetic stimulation-evoked potentials combined with electroencephalographic recording (TMS-EEG) before and after treatment (secondary outcome).

03

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • Chronic pain
  • High-Definition transcranial Direct Current Stimulation
  • HD-tDCS
  • Magnetic Resonance Imaging
  • MRI
  • functional MRI
  • structural MRI
  • Transcranial Magnetic Stimulation
  • Electroencephalography
  • EEG
  • TMS-EEG
  • Randomized Controlled Trial
  • RCT
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of chronic pain lasting for at least six months
  • Pain scores equal to or greater than 4 on Numerical Rating Scale (NRS) 0-10 on most days for the last 3 months
  • Pain unresponsive to conservative treatment such as pharmacological therapy and physiotherapy, and unresponsive to minimally invasive treatments such as peripheral nerve blocks or neuromodulation or epidural injections, when appropriate
  • Age between 18 and 75
  • Stable pain levels and willingness not to modify any ongoing pain management therapies during the study period (1 week)

Exclusion criteria

Exclusion Criteria:

  • History of seizure disorders
  • Active
  • Implanted medical devices and/or metallic implants in the head or neck region
  • Cranial abnormalities
  • Severe cognitive impairment ( (MoCA)\<15.5)
  • Neurological or psychiatric conditions, or significant comorbidities, that may interfere with tDCS
  • Pregnancy
  • Incompatibility with MRI and/or TMS
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
144 participants (estimated)

Study arms

  • Active comparator
    Cathodal

    Cathodal HD-tDCS

    Device: Cathodal High-Definition transcranial Direct Current Stimulation

  • Active comparator
    Anodal

    Anodal HD-tDCS

    Device: Anodal High-Definition transcranial Direct Current Stimulation

  • Sham comparator
    Sham

    Sham HD-tDCS

    Device: Sham (No Treatment)

Interventions

  • DeviceAnodal High-Definition transcranial Direct Current Stimulation

    Participants will receive 5 stimulation sessions in a week, with the HD-tDCS setup including 6 electrodes (3 anode + 3 cathode electrodes) delivering a total current of 2mA. The spatial configuration of the six electrodes is aimed to induce the maximum intensity of stimulation at the target stereotactic coordinate, based on the modeling of estimated distribution of electric fields. The active stimulation lasts for 20 minutes.

  • DeviceCathodal High-Definition transcranial Direct Current Stimulation

    Participants will receive 5 stimulation sessions in a week, with the HD-tDCS setup including 6 electrodes (3 anode + 3 cathode electrodes) delivering a total current of 2mA. The spatial configuration of the six electrodes is aimed to induce the maximum intensity of stimulation at the target stereotactic coordinate, based on the modeling of estimated distribution of electric fields. The active stimulation lasts for 20 minutes. In cathodal sessions, polarity is reversed.

  • DeviceSham (No Treatment)

    Participants will receive 5 stimulation sessions in a week, with the HD-tDCS setup including 6 electrodes (3 anode + 3 cathode electrodes) delivering a total current of 2mA. The spatial configuration of the six electrodes is aimed to induce the maximum intensity of stimulation at the target stereotactic coordinate, based on the modeling of estimated distribution of electric fields. In sham sessions, the duration is also 20 minutes but participants are unaware that the stimulation intensity gradually ramps down to 0 mA after 30 seconds and then ramps up again during the final 30 seconds.

06

What researchers measure

Primary outcomes

  1. Reduction of perceived pain

    We aim to assess the effect of a personalized (MRI-based) HD-tDCS protocol targeting dACC on clinical measures of perceived chronic pain. To this purpose, patients will be randomly assigned to 3 groups, each undergoing either cathodal, anodal or sham HD-tDCS treatment. Neurostimulation effects will be assessed with self-reported measures of perceived pain, collected via validated subjective functional questionnaires at 3 timepoints: before and after a 1-week (5 sessions) treatment, and at a 3 months follow-up assessment. The BPI score will be indeed considered the primary outcome measure for assessing the effect of HD-tDCS treatment, which will be deemed effective if a 30% reduction of pain intensity and interference on the BPI will be reached. The same statistical approach will be applied to the other clinical scales administered. In case of normality violations, data will be analyzed by means of non-parametric tests.

    Time frame: Baseline; Up to 3 weeks; After 3 months

Secondary outcomes

  1. Change in pain-related neural sensitivity measured with fMRI and TMS-EEG

    Participants will undergo both fMRI and TMS-EEG sessions at the two main timepoints (pre- and post-treatment). For both techniques, data will be collected during a) resting-state (cross-fixation); b) observation of pain-related/unrelated facial expressions and bodily stimulations (Jauniaux et al., 2019). The T1-weighted MRI image collected on the pre-treatment session will be used for personalized targeting/modeling of HD-tDCS electric fields, and for neuronavigation in TMS-EEG sessions.

    Time frame: Baseline; Up to 3 weeks

07

Study locations

4 of 4 sites recruiting
08

References and documents

Publications

  • Roth, Y., Padberg, F., and Zangen, A. (2007). Transcranial magnetic stimulation of deep brain regions: principles and methods. ADVANCES IN BIOLOGICAL PSYCHIATRY-BASEL-, 23(R), 204.
  • Garg, A., and Mago, V. (2021). Role of machine learning in medical research: A survey. Computer science review, 40, 100370.
  • Xiong HY, Cao YQ, Du SH, Yang QH, He SY, Wang XQ. Effects of High-Definition Transcranial Direct Current Stimulation Targeting the Anterior Cingulate Cortex on the Pain Thresholds: A Randomized Controlled Trial. Pain Med. 2023 Jan 4;24(1):89-98. doi: 10.1093/pm/pnac135. PubMed 36066447 ↗
  • Xiao X, Ding M, Zhang YQ. Role of the Anterior Cingulate Cortex in Translational Pain Research. Neurosci Bull. 2021 Mar;37(3):405-422. doi: 10.1007/s12264-020-00615-2. Epub 2021 Feb 10. PubMed 33566301 ↗
  • Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. Catastrophizing-a prognostic factor for outcome in patients with low back pain: a systematic review. Spine J. 2014 Nov 1;14(11):2639-57. doi: 10.1016/j.spinee.2014.03.003. Epub 2014 Mar 7. PubMed 24607845 ↗
  • Varoli E, Pisoni A, Mattavelli GC, Vergallito A, Gallucci A, Mauro LD, Rosanova M, Bolognini N, Vallar G, Romero Lauro LJ. Tracking the Effect of Cathodal Transcranial Direct Current Stimulation on Cortical Excitability and Connectivity by Means of TMS-EEG. Front Neurosci. 2018 May 15;12:319. doi: 10.3389/fnins.2018.00319. eCollection 2018. PubMed 29867330 ↗
  • Van Ryckeghem DML, Crombez G, Goubert L, De Houwer J, Onraedt T, Van Damme S. The predictive value of attentional bias towards pain-related information in chronic pain patients: a diary study. Pain. 2013 Mar;154(3):468-475. doi: 10.1016/j.pain.2012.12.008. Epub 2012 Dec 28. PubMed 23375161 ↗
  • Truini A, Aleksovska K, Anderson CC, Attal N, Baron R, Bennett DL, Bouhassira D, Cruccu G, Eisenberg E, Enax-Krumova E, Davis KD, Di Stefano G, Finnerup NB, Garcia-Larrea L, Hanafi I, Haroutounian S, Karlsson P, Rakusa M, Rice ASC, Sachau J, Smith BH, Sommer C, Tolle T, Valls-Sole J, Veluchamy A. Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment. Eur J Neurol. 2023 Aug;30(8):2177-2196. doi: 10.1111/ene.15831. Epub 2023 May 30. PubMed 37253688 ↗
  • Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019 Jan;160(1):19-27. doi: 10.1097/j.pain.0000000000001384. PubMed 30586067 ↗
  • Tetreault P, Mansour A, Vachon-Presseau E, Schnitzer TJ, Apkarian AV, Baliki MN. Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials. PLoS Biol. 2016 Oct 27;14(10):e1002570. doi: 10.1371/journal.pbio.1002570. eCollection 2016 Oct. PubMed 27788130 ↗
  • Romero Lauro LJ, Rosanova M, Mattavelli G, Convento S, Pisoni A, Opitz A, Bolognini N, Vallar G. TDCS increases cortical excitability: direct evidence from TMS-EEG. Cortex. 2014 Sep;58:99-111. doi: 10.1016/j.cortex.2014.05.003. Epub 2014 Jun 6. PubMed 24998337 ↗
  • Rogachov A, Cheng JC, Erpelding N, Hemington KS, Crawley AP, Davis KD. Regional brain signal variability: a novel indicator of pain sensitivity and coping. Pain. 2016 Nov;157(11):2483-2492. doi: 10.1097/j.pain.0000000000000665. PubMed 27429176 ↗
  • Pisoni A, Romero Lauro LJ, Vergallito A, Maddaluno O, Bolognini N. Cortical dynamics underpinning the self-other distinction of touch: A TMS-EEG study. Neuroimage. 2018 Sep;178:475-484. doi: 10.1016/j.neuroimage.2018.05.078. Epub 2018 May 31. PubMed 29860085 ↗
  • Perez-Borrego YA, Campolo M, Soto-Leon V, Rodriguez-Matas MJ, Ortega E, Oliviero A. Pain treatment using tDCS in a single patient: tele-medicine approach in non-invasive brain simulation. Brain Stimul. 2014 Mar-Apr;7(2):334-5. doi: 10.1016/j.brs.2013.11.008. Epub 2013 Dec 7. No abstract available. PubMed 24389501 ↗
  • Nguyen JP, Nizard J, Keravel Y, Lefaucheur JP. Invasive brain stimulation for the treatment of neuropathic pain. Nat Rev Neurol. 2011 Sep 20;7(12):699-709. doi: 10.1038/nrneurol.2011.138. PubMed 21931348 ↗
  • Meints SM, Edwards RR, Gilligan C, Schreiber KL. Behavioral, Psychological, Neurophysiological, and Neuroanatomic Determinants of Pain. J Bone Joint Surg Am. 2020 May 20;102 Suppl 1(Suppl 1):21-27. doi: 10.2106/JBJS.20.00082. No abstract available. PubMed 32251127 ↗
  • Mattavelli G, Lo Presti S, Tornaghi D, Canessa N. High-definition transcranial direct current stimulation of the dorsal anterior cingulate cortex modulates decision-making and executive control. Brain Struct Funct. 2022 Jun;227(5):1565-1576. doi: 10.1007/s00429-022-02456-3. Epub 2022 Jan 31. PubMed 35102442 ↗
  • Malfliet A, Coppieters I, Van Wilgen P, Kregel J, De Pauw R, Dolphens M, Ickmans K. Brain changes associated with cognitive and emotional factors in chronic pain: A systematic review. Eur J Pain. 2017 May;21(5):769-786. doi: 10.1002/ejp.1003. Epub 2017 Feb 1. PubMed 28146315 ↗
  • Majedi H, Amini MH, Yousefshahi F, Khazaeipour Z, Majedi M, Rahimi M, Orandi A. Predicting Factors of Pain Duration in Patients with Chronic Pain: A Large Population-based Study. Anesth Pain Med. 2020 Feb 10;10(1):e95776. doi: 10.5812/aapm.95776. eCollection 2020 Feb. PubMed 32337167 ↗
  • Luedtke K, Rushton A, Wright C, Jurgens T, Polzer A, Mueller G, May A. Effectiveness of transcranial direct current stimulation preceding cognitive behavioural management for chronic low back pain: sham controlled double blinded randomised controlled trial. BMJ. 2015 Apr 16;350:h1640. doi: 10.1136/bmj.h1640. PubMed 25883244 ↗
  • Lu C, Yang T, Zhao H, Zhang M, Meng F, Fu H, Xie Y, Xu H. Insular Cortex is Critical for the Perception, Modulation, and Chronification of Pain. Neurosci Bull. 2016 Apr;32(2):191-201. doi: 10.1007/s12264-016-0016-y. Epub 2016 Feb 22. PubMed 26898298 ↗
  • Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol. 2007 Dec;118(12):2730-44. doi: 10.1016/j.clinph.2007.09.061. Epub 2007 Oct 30. PubMed 17977787 ↗
  • Lefaucheur JP. The use of repetitive transcranial magnetic stimulation (rTMS) in chronic neuropathic pain. Neurophysiol Clin. 2006 May-Jun;36(3):117-24. doi: 10.1016/j.neucli.2006.08.002. Epub 2006 Aug 23. PubMed 17046606 ↗
  • Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipovic SR, Grefkes C, Hasan A, Hummel FC, Jaaskelainen SK, Langguth B, Leocani L, Londero A, Nardone R, Nguyen JP, Nyffeler T, Oliveira-Maia AJ, Oliviero A, Padberg F, Palm U, Paulus W, Poulet E, Quartarone A, Rachid F, Rektorova I, Rossi S, Sahlsten H, Schecklmann M, Szekely D, Ziemann U. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528. doi: 10.1016/j.clinph.2019.11.002. Epub 2020 Jan 1. PubMed 31901449 ↗
  • Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B, Marangolo P, Mylius V, Nitsche MA, Padberg F, Palm U, Poulet E, Priori A, Rossi S, Schecklmann M, Vanneste S, Ziemann U, Garcia-Larrea L, Paulus W. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017 Jan;128(1):56-92. doi: 10.1016/j.clinph.2016.10.087. Epub 2016 Oct 29. PubMed 27866120 ↗
  • Kucyi A, Davis KD. The dynamic pain connectome. Trends Neurosci. 2015 Feb;38(2):86-95. doi: 10.1016/j.tins.2014.11.006. Epub 2014 Dec 22. PubMed 25541287 ↗
  • Jauniaux J, Khatibi A, Rainville P, Jackson PL. A meta-analysis of neuroimaging studies on pain empathy: investigating the role of visual information and observers' perspective. Soc Cogn Affect Neurosci. 2019 Aug 31;14(8):789-813. doi: 10.1093/scan/nsz055. PubMed 31393982 ↗
  • Garcia-Larrea L, Peyron R. Pain matrices and neuropathic pain matrices: a review. Pain. 2013 Dec;154 Suppl 1:S29-S43. doi: 10.1016/j.pain.2013.09.001. Epub 2013 Sep 8. PubMed 24021862 ↗
  • Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007 Sep;8(9):700-11. doi: 10.1038/nrn2201. PubMed 17704812 ↗
  • Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev. 2021 Jan 1;101(1):259-301. doi: 10.1152/physrev.00045.2019. Epub 2020 Jun 25. PubMed 32584191 ↗
  • Fertonani A, Ferrari C, Miniussi C. What do you feel if I apply transcranial electric stimulation? Safety, sensations and secondary induced effects. Clin Neurophysiol. 2015 Nov;126(11):2181-8. doi: 10.1016/j.clinph.2015.03.015. Epub 2015 Apr 11. PubMed 25922128 ↗
  • Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, Jensen TS, Latremoliere A, Markman JD, Rice ASC, Rowbotham M, Staud R, Tate S, Woolf CJ, Andrews NA, Carr DB, Colloca L, Cosma-Roman D, Cowan P, Diatchenko L, Farrar J, Gewandter JS, Gilron I, Kerns RD, Marchand S, Niebler G, Patel KV, Simon LS, Tockarshewsky T, Vanhove GF, Vardeh D, Walco GA, Wasan AD, Wesselmann U. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. J Pain. 2023 Feb;24(2):204-225. doi: 10.1016/j.jpain.2022.08.010. Epub 2022 Oct 2. PubMed 36198371 ↗
  • Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. doi: 10.1016/j.pain.2004.09.012. No abstract available. PubMed 15621359 ↗
  • Dmochowski JP, Datta A, Bikson M, Su Y, Parra LC. Optimized multi-electrode stimulation increases focality and intensity at target. J Neural Eng. 2011 Aug;8(4):046011. doi: 10.1088/1741-2560/8/4/046011. Epub 2011 Jun 10. PubMed 21659696 ↗
  • Dmochowski JP, Datta A, Huang Y, Richardson JD, Bikson M, Fridriksson J, Parra LC. Targeted transcranial direct current stimulation for rehabilitation after stroke. Neuroimage. 2013 Jul 15;75:12-19. doi: 10.1016/j.neuroimage.2013.02.049. Epub 2013 Mar 5. PubMed 23473936 ↗
  • Diwadkar VA, Asemi A, Burgess A, Chowdury A, Bressler SL. Potentiation of motor sub-networks for motor control but not working memory: Interaction of dACC and SMA revealed by resting-state directed functional connectivity. PLoS One. 2017 Mar 9;12(3):e0172531. doi: 10.1371/journal.pone.0172531. eCollection 2017. PubMed 28278267 ↗
  • Davis KD, Flor H, Greely HT, Iannetti GD, Mackey S, Ploner M, Pustilnik A, Tracey I, Treede RD, Wager TD. Brain imaging tests for chronic pain: medical, legal and ethical issues and recommendations. Nat Rev Neurol. 2017 Oct;13(10):624-638. doi: 10.1038/nrneurol.2017.122. Epub 2017 Sep 8. PubMed 28884750 ↗
  • Datta A, Bansal V, Diaz J, Patel J, Reato D, Bikson M. Gyri-precise head model of transcranial direct current stimulation: improved spatial focality using a ring electrode versus conventional rectangular pad. Brain Stimul. 2009 Oct;2(4):201-7, 207.e1. doi: 10.1016/j.brs.2009.03.005. PubMed 20648973 ↗
  • Cormier S, Lavigne GL, Choiniere M, Rainville P. Expectations predict chronic pain treatment outcomes. Pain. 2016 Feb;157(2):329-338. doi: 10.1097/j.pain.0000000000000379. PubMed 26447703 ↗
  • Chowdhury NS, Chiang AK, Millard SK, Skippen P, Chang WJ, Seminowicz DA, Schabrun SM. Alterations in cortical excitability during pain: A combined TMS-EEG Study. bioRxiv [Preprint]. 2023 Aug 7:2023.04.20.537735. doi: 10.1101/2023.04.20.537735. PubMed 37131586 ↗
  • Casarotto S, Romero Lauro LJ, Bellina V, Casali AG, Rosanova M, Pigorini A, Defendi S, Mariotti M, Massimini M. EEG responses to TMS are sensitive to changes in the perturbation parameters and repeatable over time. PLoS One. 2010 Apr 22;5(4):e10281. doi: 10.1371/journal.pone.0010281. PubMed 20421968 ↗
  • Auvichayapat P, Keeratitanont K, Janyachareon T, Auvichayapat N. The effects of transcranial direct current stimulation on metabolite changes at the anterior cingulate cortex in neuropathic pain: a pilot study. J Pain Res. 2018 Oct 11;11:2301-2309. doi: 10.2147/JPR.S172920. eCollection 2018. PubMed 30349356 ↗
  • Alwardat M, Pisani A, Etoom M, Carpenedo R, Chine E, Dauri M, Leonardis F, Natoli S. Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis. J Neural Transm (Vienna). 2020 Sep;127(9):1257-1270. doi: 10.1007/s00702-020-02223-w. Epub 2020 Jul 9. PubMed 32647923 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Feb 2027, 22 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 22 months is close to that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2026
First posted
Feb 25, 2026
StartActual
Apr 3, 2025
Primary completionEst.
Feb 28, 2027
CompletionEst.
May 31, 2027
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07432841
Collaborators
University of Milano Bicocca, IRCCS ISMETT Palermo, University of Palermo
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Apr 3, 2025
Primary completion
Feb 28, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Feb 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion